Joseph Truitt - Net Worth and Insider Trading
Joseph Truitt Net Worth
The estimated net worth of Joseph Truitt is at least $41,920 dollars as of 2024-11-29. Joseph Truitt is the CEO of Achillion Pharmaceuticals Inc and owns about 3,500 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $23,660. Joseph Truitt is also the Director of Larimar Therapeutics Inc and owns about 2,750 shares of Larimar Therapeutics Inc (LRMR) stock worth over $18,260. Details can be seen in Joseph Truitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Truitt has not made any transactions after 2023-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Truitt
Joseph Truitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Truitt owns 3 companies in total, including Larimar Therapeutics Inc (LRMR) , BioSpecifics Technologies Corp (BSTC) , and Achillion Pharmaceuticals Inc (ACHN) .
Click here to see the complete history of Joseph Truitt’s form 4 insider trades.
Insider Ownership Summary of Joseph Truitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2023-05-17 | director |
| BSTC | BioSpecifics Technologies Corp | 2020-05-28 | director & Chief Executive Officer |
| ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | director & Chief Executive Officer |
Joseph Truitt Latest Holdings Summary
Joseph Truitt currently owns a total of 2 stocks. Among these stocks, Joseph Truitt owns 3,500 shares of Achillion Pharmaceuticals Inc (ACHN) as of October 16, 2019, with a value of $23,660 and a weighting of 56.44%. Joseph Truitt also owns 2,750 shares of Larimar Therapeutics Inc (LRMR) as of May 17, 2023, with a value of $18,260 and a weighting of 43.56%.
Latest Holdings of Joseph Truitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2019-10-16 | 3,500 | 6.76 | 23,660 |
| LRMR | Larimar Therapeutics Inc | 2023-05-17 | 2,750 | 6.64 | 18,260 |
Holding Weightings of Joseph Truitt
Joseph Truitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Truitt has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 133,484 shares on October 16, 2019, which brought Joseph Truitt around $850,293.
According to the SEC Form 4 filings, Joseph Truitt has made a total of 1 transactions in Larimar Therapeutics Inc (LRMR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Larimar Therapeutics Inc is the acquisition of 2,750 shares on May 17, 2023, which cost Joseph Truitt around $10,258.
Insider Trading History of Joseph Truitt
- 1
Joseph Truitt Trading Performance
GuruFocus tracks the stock performance after each of Joseph Truitt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Truitt is 2.67%. GuruFocus also compares Joseph Truitt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Truitt within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Truitt's insider trading performs compared to the benchmark.
Performance of Joseph Truitt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.43 | | | | | |
| Relative Return to S&P 500(%) | -8.51 | | | | | |
Joseph Truitt Ownership Network
Joseph Truitt Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Joseph Truitt is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Joseph Truitt made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,354,825 shares were bought by its insiders, resulting in a net purchase of 4,354,825 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Joseph Truitt Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Truitt. You might contact Joseph Truitt via mailing address: C/o Achillion Pharmaceuticals, Inc., 300 George Street, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
